Medindia
Medindia LOGIN REGISTER
Advertisement

Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

Thursday, February 28, 2019 General News
Advertisement

Reconciliation of Net Debt Leverage Ratio (non-GAAP)

The following table provides a reconciliation of our Net loss (GAAP) to our Adjusted EBITDA (non-GAAP) for the twelve months ended December 31, 2018 (in thousands) and the calculation of our Net Debt Leverage Ratio (non-GAAP):

Twelve Months Ended December 31, 2018

Net loss (GAAP)

$

(1,031,469)

Income tax expense

22,935

Interest expense, net

521,656

Depreciation and amortization (15)

688,530

EBITDA (non-GAAP)

$

201,652

Inventory step-up and other cost savings

$

261

Upfront and milestone-related payments

45,108

Inventory reserve increase from restructuring

2,947

Separation benefits and other restructuring

83,348

Certain litigation-related and other contingencies, net

13,809

Asset impairment charges

916,939

Acquisition-related and integration costs

2,004

Fair value of contingent consideration

19,910

Loss on extinguishment of debt



Share-based compensation

54,071

Other income, net

(51,953)

Other adjustments

(737)

Discontinued operations, net of tax

69,702

Adjusted EBITDA (non-GAAP)

$

1,357,061

Calculation of Net Debt:

Debt

$

8,258,419

Cash (excluding Restricted Cash)

1,149,113

Net Debt (non-GAAP)

$

7,109,306

Calculation of Net Debt Leverage:

Net Debt Leverage Ratio (non-GAAP)

5.2

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close